Public filings / ASND on Yahoo Finance (opens in a new tab)
ASND: insider buying, 13F holders, analyst moves
Ascendis Pharma A/S - US
A summary of public filings about Ascendis Pharma A/S - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
4 of our 100 managers hold ASND
Combined reported value $4.42B.
Holders among our 100 managers: 0 in Q3 2023, 4 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| RA Capital | $2.74B | 23.83% | New |
| Avoro Capital Advisors | $1.36B | 12.24% | New |
| Perceptive Advisors | $310.4M | 4.82% | New |
| Tudor Investment | $4.4M | 0.02% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.